CUSP9v3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CUSP9v3, covering 2021-10-05 to 2021-10-05. Get the full timeline:
Most recent: Clinical Trial Update: A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma [Phase 1, Phase 2]